New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
Chemotherapy plays a key role in breast cancer therapy, but drug resistance and unwanted side effects make the treatment less effective. We propose a new combination model that combines antineoplastic drugs and antimalarials for breast cancer therapy. Cytotoxic effects of two antineoplastic agents a...
Main Authors: | Diana Duarte, Nuno Vale |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/12/1623 |
Similar Items
-
Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs
by: Diana Duarte, et al.
Published: (2021-07-01) -
The journey of antimalarial drugs against SARS-CoV-2: Review article
by: Amany A. Sarhan, et al.
Published: (2021-01-01) -
Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
by: Earnest Oghenesuvwe Erhirhie, et al.
Published: (2021-01-01) -
Drug combination and repurposing for cancer therapy: the example of breast cancer
by: Ana Salomé Correia, et al.
Published: (2021-01-01) -
Antimalarial drug resistance and the importance of drug quality monitoring
by: Green M
Published: (2006-01-01)